Publications at the BMWZ
Showing results 181 - 190 out of 279
2015
Bowman, A., Lercher, L., Singh, H. R., Zinne, D., Timinszky, G., Carlomagno, T., & Ladurner, A. G. (2015). The histone chaperone sNASP binds a conserved peptide motif within the globular core of histone H3 through its TPR repeats. Nucleic acids research, 44(7), 3105-3117. https://doi.org/10.1093/nar/gkv1372
Bułyszko, I., Dräger, G., Klenge, A., & Kirschning, A. (2015). Evaluation of the Synthetic Potential of an AHBA Knockout Mutant of the Rifamycin Producer Amycolatopsis mediterranei. Chemistry - A European Journal, 21(52), 19231-19242. https://doi.org/10.1002/chem.201503548
Franke, J., Bock, M., Dehn, R., Fohrer, J., Mhaske, S. B., Migliorini, A., Kanakis, A. A., Jansen, R., Herrmann, J., Müller, R., & Kirschning, A. (2015). Total and semi-syntheses of antimicrobial thuggacin derivatives. Chemistry - A European Journal, 21(11), 4272-4284. https://doi.org/10.1002/chem.201405874
Hartwig, J., & Kirschning, A. (2015). Iterative Syntheses: The Gateway to New Automation Protocols. Angewandte Chemie , 54(36), 10412-10414. https://doi.org/10.1002/anie.201504615, https://doi.org/10.1002/ange.201504615
Hermane, J., Bułyszko, I., Eichner, S., Sasse, F., Collisi, W., Poso, A., Schax, E., Walter, J. G., Scheper, T., Kock, K., Herrmann, C., Aliuos, P., Reuter, G., Zeilinger, C., & Kirschning, A. (2015). New, Non‐quinone Fluorogeldanamycin Derivatives Strongly Inhibit Hsp90. CHEMBIOCHEM, 16(2), 302-311. https://doi.org/10.1002/cbic.201402375
Jürjens, G., Kirschning, A., & Candito, D. A. (2015). Lessons from the Synthetic Chemist Nature. Natural Product Reports, 32(5), 723-737. https://doi.org/10.1039/c4np00160e
Kirschning, A., & Reydon, T. A. C. (2015). Is organic chemistry science: And does this question make any sense at all? Beilstein Journal of Organic Chemistry, 11, 893-896. https://doi.org/10.3762/bjoc.11.100
Lu, H. H., Hinkelmann, B., Tautz, T., Li, J., Sasse, F., Franke, R., & Kalesse, M. (2015). Paleo-soraphens: Chemical total syntheses and biological studies. Organic and Biomolecular Chemistry, 13(29), 8029-8036. https://doi.org/10.1039/c5ob01249j
Moreno, M., Elgaher, W. A. M., Herrmann, J., Schläger, N., Hamed, M. M., Baumann, S., Müller, R., Hartmann, R. W., & Kirschning, A. (2015). Synthesis and biological evaluation of cystobactamid 507: A bacterial topoisomerase inhibitor from Cystobacter sp. Synlett, 26(9), 1175-1178. Article st-2015-b0058-l. https://doi.org/10.1055/s-0034-1380509
Perin, P. M., Haid, S., Brown, R. J. P., Doerrbecker, J., Schulze, K., Zeilinger, C., von Schaewen, M., Heller, B., Vercauteren, K., Luxenburger, E., Baktash, Y. M., Vondran, F. W. R., Speerstra, S., Awadh, A., Mukhtarov, F., Schang, L. M., Kirschning, A., Müller, R., Guzman, C. A., ... Pietschmann, T. (2015). Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1. Hepatology, 63(1), 49-62. https://doi.org/10.1002/hep.28111
